BRIEF — Astrazeneca Says Klygefa Recommended For EU Approval To Treat Adults With Generalized Myasthenia Gravis
Sept 18 (Reuters) — AstraZeneca PLC: Astrazeneca: Klygefa (Gefurulimab) Recommended For Approval In Eu By Chmp For Treatment Of Adults With Generalised Myasthenia Gravis (Gmg) Source text:... Further company coverage: AZN.L (Reuters.Briefs@thomsonreuters.com;)
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.